Cogstate’s Post

View organization page for Cogstate, graphic

34,227 followers

In sleep-related clinical drug development, understanding the relationship between cognition, sedation, and wakefulness is pivotal for safety and efficacy decision making. Gather insights from Cogstate’s CIO, Paul Maruff, describing how cognitive assessments are used to inform decisions about mechanism of action, dosing, length of effect, and consequences on thinking of new therapeutic compounds. Read data and case examples from trials of benzodiazepines, sleep restriction studies, and Lemborexant and the PVT 👉 https://lnkd.in/d2PfhbAY

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics